Skip to main content
SpringerLink
Log in

Continuous medical therapy with H2-antagonists: the best option in peptic ulcer disease

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Continuous medical therapy with H2-antagonists: the best option in peptic ulcer disease. Inpharma Wkly. 666, 4 (1988). https://doi.org/10.1007/BF03309295

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309295

Keywords

Search

Navigation